(Q41137180)

English

Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus

scientific article published on 30 March 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

oncolytic virus

1 reference

based on heuristic

inferred from title

immunosuppression

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Derek R Clements

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Andra M Sterea

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Youra Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Erin Helson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Cheryl A Dean

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Anna Nunokawa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Tanveer Sharif

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Paola Marcato

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Shashi A Gujar

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Patrick W K Lee

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

0 references

publication date

30 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

194

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

4397-4412

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Breakthrough of the year 2013. Cancer immunotherapy

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Ovarian cancer immunotherapy: opportunities, progresses and challenges

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Cancer immunotherapy comes of age

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Immunology beats cancer: a blueprint for successful translation

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Reovirus: a targeted therapeutic--progress and potential

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

VSV-tumor selective replication and protein translation

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Maraba virus as a potent oncolytic vaccine vector

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Development of transcriptionally regulated oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Oncolytic virus-initiated protective immunity against prostate cancer

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replication

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Reovirus activates human dendritic cells to promote innate antitumor immunity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Tumor infection by oncolytic reovirus primes adaptive antitumor immunity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Reciprocal relationship between myeloid-derived suppressor cells and T cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Myeloid-derived suppressor cells in parasitic infections

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Development of a syngeneic mouse model for events related to ovarian cancer

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Flow cytometric quantification of T cell proliferation and division kinetics in woodchuck model of hepatitis B.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Oncolytic virus-mediated reversal of impaired tumor antigen presentation

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Coordinated regulation of myeloid cells by tumours

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Myeloid-derived suppressor cells: linking inflammation and cancer

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402132

21 January 2018

Identifiers

10.4049/JIMMUNOL.1402132

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25825443%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41137180&oldid=2094148124"